Press Release | Thu Nov 7, 2013 10:26am EST

Researchers to Present Clinical Trial Data With Soliris® (eculizumab) Treatment in Both Approved Indications – PNH and aHUS – at ASH Annual Meeting

* Reuters is not responsible for the content in this press release.